Literature DB >> 3066790

Immunocytochemical localization of ras p21 product in thyroid follicular cells of normal rats using monoclonal antibody RAP-5.

Y Mizukami1, A Nonomura, T Hashimoto, E Kawahara, S Matsukawa, F Matsubara.   

Abstract

The ultrastructural localization of ras p21 product was studied immunocytochemically in thyroid follicular cells of normal rats using pre-embedded peroxidase-labelled antibody techniques and a monoclonal antibody, RAP-5, which had been raised against a synthetic peptide corresponding to amino acid positions 10-17 of the ras p21 protein. The ras p21 product was detected in cisternae of rough endoplasmic reticulum, Golgi apparatus and the subapical portion of apical plasma membrane, in which it was most concentrated. This study indicated that the p21 product may be synthesized in the rough endoplasmic reticulum and finally localized at the subapical portion of the thyroid follicular cells, and also that the apical plasma membrane may be a major site for the reception of environmental stimuli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3066790     DOI: 10.1007/bf01324082

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  20 in total

1.  Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

Authors:  A K Ghosh; M Moore; M Harris
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

2.  Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.

Authors:  Y Mizukami; A Nonomura; T Hashimoto; S Terahata; F Matsubara; T Michigishi; M Noguchi
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

3.  Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs.

Authors:  L S Ulsh; T Y Shih
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

4.  Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.

Authors:  T L Johnson; R V Lloyd; A Thor
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

5.  Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

Authors:  P H Hand; A Thor; D Wunderlich; R Muraro; A Caruso; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

7.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

8.  Localization of adenylate cyclase and 5'-nucleotidase activities in human thyroid follicular cells.

Authors:  Y Mizukami; F Matsubara; S Matsukawa
Journal:  Histochemistry       Date:  1982

9.  ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; J Schlom
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

10.  Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.

Authors:  A R Williams; J Piris; D A Spandidos; A H Wyllie
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.